Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNU6-538P** is a member of the U6 small nuclear RNA (snRNA) pseudogene family, which means it is a nonfunctional copy of the gene encoding U6 snRNA[1][5][7]. U6 snRNA itself is an essential component of the spliceosome, a complex responsible for pre-mRNA splicing in eukaryotes[5]. The RNU6-538P gene arises via duplication or retrotransposition and has lost the ability to encode a functional RNA or protein[1][6][7]. Although pseudogenes are sometimes transcribed and can have regulatory effects (such as acting as miRNA decoys or influencing the expression of related genes), there is no direct evidence that RNU6-538P has a defined physiological or pathological role[2][6]. RNU6-538P is not a direct therapeutic target. It belongs to the broader category of pseudogenes, which can occasionally have regulatory or disease-related roles, but RNU6-538P specifically lacks such established functions. The name and classification are accurate; it is representative of non-coding, non-protein-coding genomic elements derived from small nuclear RNAs[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 538, pseudogene (RNU6-538P).